The groundbreaking treatment of tirzepatide peptide represents a exciting advance in the handling of type 2 diabetes. Different to existing drugs, tirzepatide affects multiple pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment